September 7, 2016
Daiichi Sankyo, Inc. (Edison,NJ) announced the appointment of Marielle Cohard-Radice, M.D., as Executive Vice President, Global Head of Development.
In her new role, Dr. Cohard-Radice will have responsibility for the development strategy and portfolio planning for the Cardiovascular-Metabolism and Internal Medicine therapeutic areas.
Prior to her promotion, Marielle Cohard-Radice was Vice President of Clinical Development Operations at Daiichi Sankyo Pharma Development, a position she held since 2012.
The former Global Head of Development, Mahmoud Ghazzi, M.D., Ph.D, has decided to leave the company.
Can Data and AI Deliver Whole-Person Health?
July 9th 2024Executives in the life sciences and medical device industries see promise in artificial intelligence (AI) and medical technologies, but must also navigate the changing healthcare ecosystem, varied stakeholder needs, and the impact of AI on market access and commercialization strategies.